Atrial Appendage Occluder Market
Explore FMI’s in-depth coverage on the Atrial Appendage Occluder Market to gain Exhaustive Analyses of Key Segments
Atrial Appendage Occluder Market by Type of Indication, Positioning of Device, End User& Region - Forecast 2022 – 2032
Atrial Appendage Occluder Market Snapshot (2022-2032)
[250 Pages Report] The global atrial appendage occluder market garnered a market value of US$ 854.6 Million in 2022 and is expected to register a staggering double-digit CAGR of 23.95% by accumulating a market value of US$ 7,316.9 Million in the forecast period 2022-2032.
Growth of the market can be attributed to the increasing geriatric population especially in North America and Europe. The market for atrial appendage occluder registered a CAGR of 8% in the historical period 2016-2021.
|
Data Points |
Key Statistics |
|
Expected Market Value (2022) |
US$ 854.6 Million |
|
Anticipated Forecast Value (2032) |
US$ 7,316.9 Million |
|
Projected Growth Rate (2022-2032) |
23.95% CAGR |
Atrial appendage, better described as left atrial appendage (LAA) is an ear-shaped pouch present in the top left chamber of the human heart (Left Atrium). The functional significance of this structure is unknown. In patients living with arrhythmic cardiovascular conditions such as atrial fibrillation, blood accumulates in the left atrial appendage and can cause clotting of blood.
The blood clots can cause fatal stroke when pumped into the blood vessels. Along with oral anticoagulants, occlusion of LAA by an occluder is an alternative approach to protect cardiovascular patients from strokes and other complications. Atrial appendage occluder is thus a kind of plug that permanently closes the appendage.
According to a study published in the journal, Clinical Medical Insights: Cardiology, atrial fibrillation affects around 2 percent of the global population and the prevalence of the disease is expected to increase five times over the next four decades, especially in the United States, owing to the expanding elderly population base.
Let us know your requirement to get
100% FREE customization
Atrial Appendage Occluder Market Demand Analysis (2016 To 2021) Vs Market Outlook (2022 To 2032)
The global demand for atrial appendage occluders is projected to rise at a CAGR of 23.95% during the forecast period between 2022 and 2032, reaching a total of US$ 854.6 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 8%.
The increasing number of cardiovascular patients suffering from atrial fibrillation and thromboembolism is the primary factor contributing to market growth. People's changing lifestyles, as well as the growing number of people suffering from obesity, diabetes, and hypertension, are increasing demand for the devices, contributing to market growth.
In the upcoming years, atrial appendage occluder market systems are expected to gain prominence as most new construction sites are already installing the same as a necessity. With the construction industry developing rapidly in emerging regions, the demand for Atrial appendage occluder market expected to rise.
Certain factors, such as the limited use of the LAA occluder for patients who have a high risk of bleeding as well as stroke while on anticoagulant therapy, are limiting the market's growth. Other factors limiting market growth include unfavourable policies and complications associated with surgery.
Which Are Some Prominent Drivers Of Atrial Appendage Occluder Market?
Growing Number of Cardiovascular Patients to Push Sales
The surging number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is a major driver to the growth of the global atrial appendage occluder market. Sedentary lifestyles and ailments like as diabetes, obesity, and hypertension will drive demand for such devices, paving the way for market expansion.
The global atrial appendage occluder market is extremely concentrated, with only a few players. Annually, roughly 15 million strokes occur worldwide, according to the World Health Organization (WHO). In 2010, the United States spent around US$ 53.9 billion on health care services, drugs, and lost work days due to a heart stroke.
Ischemic strokes account for approximately 87% of all strokes, which occur when blood circulation to the brain is compromised. Stroke is third among main causes of mortality, and it is also the leading cause of long-term disability. Around 20% of ischemic strokes are caused by atrial fibrillation. All of these factors are catalysing the growth of the atrial occluder market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Are The Challenges Faced By The Atrial Appendage Occluder Market?
Restricted Use of LAA Occluder to Stifle the Market Growth
The restricted use of LAA occluder solely for those at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion.
Furthermore, difficulties associated with device implantation and removal, such as tissue erosion, which might necessitate open heart surgery, may function as a limiting factor for market expansion. Unfavourable policies concerning endocardial LAA closure are likely to hamper market expansion.
Region-Wise Insights
A Growing Geriatric Population Driving Demand for Atrial Appendage Occluders in North America?
As per FMI, North America is anticipated to dominate the atrial appendage occluders market during the forecast period. This is because of its vast geriatric population.
Furthermore, the region's huge population, which account for the highest number of stroke deaths, are the primary cause for individuals depending on atrial appendage occluders, particularly in the United States. Thus, in 2022, North America is anticipated to have a market share of 39.8% for atrial appendage occluder.
Is the Increased Risk of Atrial Fibrillation Fuelling the European Market for Atrial Appendage Occluders?
Europe’s Sedentary Lifestyles favouring Market Growth
According to a report published in the journal Indian Pacing and Electrophysiology Journal, the European Atrial appendage occluder market is likely to rise since more than 6 million Europeans are already living with arrhythmia, and the number is expected to double over the next 50 years.
According to one study, the European race has a greater incidence of atrial fibrillation than other races. Furthermore, due of sedentary lifestyles, the number of persons with cardiovascular problems is predicted to rise in developed nations, driving market development in the future.
This, in turn, is projected to serve the atrial appendage occluder market develops. As a result of the aforementioned factors, Europe is estimated to have a market share of 27.3% in the atrial occluder market in 2022.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-Wise Insights
Which Procedure of Positioning of the Device is the Most Lucrative in the Global Atrial appendage occluder Market?
Endocardial Segment to have the Highest Demand
The endocardial segment is anticipated to have the highest market share because they are both safe and effective. Several clinical studies on endocardial devices have yielded encouraging results for the patient population in terms of stroke risk reduction, contributing to the segment's market share.
Endocardial segment is likely to have a lower complication rate (around 8.5%) than Epicardial (25.4%), which is believed to drive segment growth. Epicardial has emerged as an alternative procedure for LAA closures with the goal of improving efficacy, especially in patients who have had poor results with the standard endocardial technique.
The Epicardial segment is forecasted to account for 15% of the global atrial appendage occluder market share during the forecast period.
Which End-Use Segment is Likely to Contribute Most to the Global Atrial appendage occluder Market?
Hospital Segment to be the Most Lucrative Segment
The hospital segment of the atrial appendage occluder market is expected to grow rapidly. The growing number of hospitals and the advancement of infrastructure are expected to drive demand for the devices. According to the Centres for Medicare and Medicaid Services, the United States spent approximately 3.6 trillion US$ on health-care management in 2018. This is expected to boost the market for atrial appendage occluder.
Furthermore, the rising prevalence of atrial fibrillation is expected to play a significant role in this segment. Atrial fibrillation is one of the most common heart conditions, according to the European Society of Cardiology.
The prevalence of atrial fibrillation in people aged 65 and older was around 7.6 million in 2016, and it is expected to rise by 89%, to around 14 million by 2060.Hence, the aforementioned factors are expected to increase hospital visits for atrial appendage management, increasing demand for atrial appendage occluder in this segment.
Start-Ups for Atrial appendage occluder Market
Key startup players in the atrial appendage occluder Market are:
Mitral Valve Repair at Vesalius Cardiovascular
In open-heart surgery, replacing the mitral valve carries a significant risk of infection and other complications. Medical professionals can correct mitral valve issues without major surgery using minimally invasive procedures such as Transcatheter Mitral Valve Replacement (TMVR).
Minimally invasive procedures are significantly less expensive than open-heart surgeries because the need for hospitalization before and after the procedure is greatly reduced. The pain is also significantly reduced, allowing the patient to recover more quickly. Startups and emerging companies create cardiovascular devices to assist doctors in replacing mitral valves in patients.
- Vesalius Cardiovascular, a Canadian startup, has developed Calla, a transfemoral mitral valve repair system (TMVr). The biomedical device and delivery system developed by the startup enable percutaneous mitral valve repair. Its Orion TMVR (Transcatheter Mitral Valve Replacement) platform supplements the TMVr procedure and optimizes valve replacement. Furthermore, when repairing the mitral valve, Orion is able to eliminate common risks such as Left Ventricular Outflow Tract Obstruction (LVOTO).
MOST Cardio - Design Reusable Platform
Angioplasty is the traditional treatment for peripheral artery disease, which is caused by plaque buildup in the arteries. An atherectomy is a viable alternative to angioplasties for the treatment of atherosclerosis, a type of cholesterol and fat buildup in the arterial walls. This encourages startups to create minimally invasive endovascular solutions for clogged arteries.
MOST Cardio, based in the United States, creates cardiovascular surgical devices. The product portfolio of the startup includes proprietary guide wires with robotic guidance, proprietary catheters for plaque removal, and micro-emulsifiers for plaque emulsification.
The femoral artery is also used by the startup for minimally invasive surgeries, which reduces blood loss and potential infections. This solution also ensures that the arterial walls do not collapse or perforate while the procedure is being performed.
Market Competition
Key players in the atrial appendage occluder market include Appriva Medical Inc., Boston Scientific, Abbott, SentreHEART Inc, pfm medical ag., Occlutech, W. L. Gore & Associates, Coherex Medical, Inc., Cardia, Inc. and AtriCure, Inc. amongst others.
For developing commercial presence, these important actors focus strategic formulations such as research collaborations, new product releases, market penetration, and distribution alliances. Furthermore, these industry leaders are substantially spending in research activities, which encourage innovation and help them to commercialise improved products and maximise market income.
Recent Developments In The Atrial Appendage Occluder Market Are
- In August 2022, Abbott and WW International, Inc. established a strategic alliance to assist people with diabetes better understand and manage their diabetes and weight. The companies are collaborating to integrate WeightWatchers' diabetes-specific weight management programme with Abbott's portfolio of FreeStyle Libre® products to create a seamless mobile experience that will provide people living with diabetes with the information and insights they need to make healthy dietary adjustments, improve their glucose levels, and, ultimately, gain more control of their health.
- In July 2022, DURAMESH Suturable Mesh is being added to the product portfolio of PFM Medical AG. For the first time, this novel suturable mesh combines the benefits of mesh repair with the precise application of surgical sutures. When large pressures must be imparted, DURAMESH can be used in place of surgical sutures.
- In June 2022, Boston Scientific Corporation, announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd to acquire its majority stake in M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech invented the HANAROSTENTTM technology, a line of conformable, non-vascular, self-expanding metal stents supplied in Japan by Boston Scientific since 2015. The acquisition price is KRW 14,500 per share, for a total of KRW 291.2 billion, or roughly $230 million at current exchange rates, subject to closing adjustments.
- In June 2022, AtriCure, Inc., a pioneer in surgical treatments and therapies for atrial fibrillation, left atrial appendage (LAA) control, and post-operative pain management, announced that the first patient in the HEAL-ISTTM study has been treated (NCT 05280093). Drs. Mark LaMeir and Carlo de Asmundis treated the first patient at University Hospital Brussels. The HEAL-IST study will assess the safety and efficacy of AtriCure's Isolator® SynergyTM Clamp in the treatment of drug-resistant individuals with Inappropriate Sinus Tachycardia (IST).
- In May 2022, B. Braun Interventional Systems Inc. has secured an exclusive distribution deal with Occlutech (BIS). With the backing of the worldwide Occlutech team, BIS will begin US commercialization initiatives for Occlutech's Flex II ASD Occluder. Through the agreement, Occlutech positions itself for success in the strategically crucial US market, which is regarded as a premier and commercially appealing healthcare system, while BIS expands the relevance of its portfolio around its strong congenital and structural heart emphasis.
Report Scope
|
Report Attribute |
Details |
|
Market Value in 2022 |
US$ 854.6 Million |
|
Market value in 2032 |
US$ 7,316.9 Million |
|
Growth Rate |
CAGR of 23.95% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled In The Atrial Appendage Occluder Industry Survey
Type of indication:
- Non-valvular Atrial Fibrillation
Procedure of positioning of the device:
- Endocardial
- Epicardial
End user:
- Hospitals
- Clinics
Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Frequently Asked Questions
FMI projects the global atrial appendage occluder market to expand at a 21.3% value CAGR by 2032
The global atrial appendage occluder market is estimated at a market value of US$ 854.6 Million
The global atrial appendage occluder market is expected to garner a market value of US$ 7,316.9 Million
North America is expected to possess 39.8% market share for atrial appendage occluder market in 2022
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure Of Positioning
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Procedure Of Positioning, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure Of Positioning, 2022-2032
5.3.1. Endocardial
5.3.2. Epicardial
5.4. Y-o-Y Growth Trend Analysis By Procedure Of Positioning, 2017-2021
5.5. Absolute $ Opportunity Analysis By Procedure Of Positioning, 2022-2032
6. Global Atrial Apendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
6.3.1. Hospitals
6.3.2. Clinics
6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
7. Global Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Procedure Of Positioning
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Procedure Of Positioning
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Procedure Of Positioning
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Procedure Of Positioning
9.3.3. By End User
9.4. Key Takeaways
10. Europe Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Procedure Of Positioning
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Procedure Of Positioning
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. Rest of Asia Pacific
11.2.2. By Procedure Of Positioning
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Procedure Of Positioning
11.3.3. By End User
11.4. Key Takeaways
12. MEA Atrial Appendage Occluder Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Procedure Of Positioning
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Procedure Of Positioning
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Atrial Appendage Occluder Market Analysis
13.1. U.K.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Procedure Of Positioning
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Procedure Of Positioning
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Procedure Of Positioning
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Procedure Of Positioning
13.4.2.2. By End User
13.5. Rest of Latin America
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Procedure Of Positioning
13.5.2.2. By End User
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Procedure Of Positioning
13.6.2.2. By End User
13.7. U.K.
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Procedure Of Positioning
13.7.2.2. By End User
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Procedure Of Positioning
13.8.2.2. By End User
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Procedure Of Positioning
13.9.2.2. By End User
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Procedure Of Positioning
13.10.2.2. By End User
13.11. Rest of Europe
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Procedure Of Positioning
13.11.2.2. By End User
13.12. China
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Procedure Of Positioning
13.12.2.2. By End User
13.13. Japan
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Procedure Of Positioning
13.13.2.2. By End User
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Procedure Of Positioning
13.14.2.2. By End User
13.15. Malaysia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Procedure Of Positioning
13.15.2.2. By End User
13.16. Singapore
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Procedure Of Positioning
13.16.2.2. By End User
13.17. Australia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Procedure Of Positioning
13.17.2.2. By End User
13.18. Rest of Asia Pacific
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Procedure Of Positioning
13.18.2.2. By End User
13.19. GCC Countries
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Procedure Of Positioning
13.19.2.2. By End User
13.20. South Africa
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Procedure Of Positioning
13.20.2.2. By End User
13.21. Israel
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2021
13.21.2.1. By Procedure Of Positioning
13.21.2.2. By End User
13.22. Rest of MEA
13.22.1. Pricing Analysis
13.22.2. Market Share Analysis, 2021
13.22.2.1. By Procedure Of Positioning
13.22.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Procedure Of Positioning
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Appriva Medical Inc
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Boston Scientific
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Abbott
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. SentreHeart Inc
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. pfm medical ag.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Occlutech
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. W. L. Gore & Associates
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Coherex Medical, Inc.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Cardia, Inc.
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. AtriCure, Inc.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Atrial Occluder Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Atrial Occluder Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032
Table 3: Global Atrial Occluder Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 4: North America Atrial Occluder Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Atrial Occluder Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032
Table 6: North America Atrial Occluder Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 7: Latin America Atrial Occluder Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Atrial Occluder Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032
Table 9: Latin America Atrial Occluder Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 10: Europe Atrial Occluder Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Atrial Occluder Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032
Table 12: Europe Atrial Occluder Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 13: Asia Pacific Atrial Occluder Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Asia Pacific Atrial Occluder Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032
Table 15: Asia Pacific Atrial Occluder Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 16: MEA Atrial Occluder Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: MEA Atrial Occluder Market Value (US$ Mn) Forecast by Procedure Of Positioning, 2017-2032
Table 18: MEA Atrial Occluder Market Value (US$ Mn) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Atrial Occluder Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032
Figure 2: Global Atrial Occluder Market Value (US$ Mn) by End User, 2022-2032
Figure 3: Global Atrial Occluder Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Atrial Occluder Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Atrial Occluder Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Atrial Occluder Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Atrial Occluder Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032
Figure 8: Global Atrial Occluder Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032
Figure 9: Global Atrial Occluder Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032
Figure 10: Global Atrial Occluder Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 11: Global Atrial Occluder Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 12: Global Atrial Occluder Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 13: Global Atrial Occluder Market Attractiveness by Procedure Of Positioning, 2022-2032
Figure 14: Global Atrial Occluder Market Attractiveness by End User, 2022-2032
Figure 15: Global Atrial Occluder Market Attractiveness by Region, 2022-2032
Figure 16: North America Atrial Occluder Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032
Figure 17: North America Atrial Occluder Market Value (US$ Mn) by End User, 2022-2032
Figure 18: North America Atrial Occluder Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Atrial Occluder Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Atrial Occluder Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Atrial Occluder Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Atrial Occluder Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032
Figure 23: North America Atrial Occluder Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032
Figure 24: North America Atrial Occluder Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032
Figure 25: North America Atrial Occluder Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 26: North America Atrial Occluder Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 27: North America Atrial Occluder Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 28: North America Atrial Occluder Market Attractiveness by Procedure Of Positioning, 2022-2032
Figure 29: North America Atrial Occluder Market Attractiveness by End User, 2022-2032
Figure 30: North America Atrial Occluder Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Atrial Occluder Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032
Figure 32: Latin America Atrial Occluder Market Value (US$ Mn) by End User, 2022-2032
Figure 33: Latin America Atrial Occluder Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Atrial Occluder Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Atrial Occluder Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Atrial Occluder Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Atrial Occluder Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032
Figure 38: Latin America Atrial Occluder Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032
Figure 39: Latin America Atrial Occluder Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032
Figure 40: Latin America Atrial Occluder Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 41: Latin America Atrial Occluder Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 42: Latin America Atrial Occluder Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 43: Latin America Atrial Occluder Market Attractiveness by Procedure Of Positioning, 2022-2032
Figure 44: Latin America Atrial Occluder Market Attractiveness by End User, 2022-2032
Figure 45: Latin America Atrial Occluder Market Attractiveness by Country, 2022-2032
Figure 46: Europe Atrial Occluder Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032
Figure 47: Europe Atrial Occluder Market Value (US$ Mn) by End User, 2022-2032
Figure 48: Europe Atrial Occluder Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Atrial Occluder Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Atrial Occluder Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Atrial Occluder Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Atrial Occluder Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032
Figure 53: Europe Atrial Occluder Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032
Figure 54: Europe Atrial Occluder Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032
Figure 55: Europe Atrial Occluder Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 56: Europe Atrial Occluder Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 57: Europe Atrial Occluder Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 58: Europe Atrial Occluder Market Attractiveness by Procedure Of Positioning, 2022-2032
Figure 59: Europe Atrial Occluder Market Attractiveness by End User, 2022-2032
Figure 60: Europe Atrial Occluder Market Attractiveness by Country, 2022-2032
Figure 61: Asia Pacific Atrial Occluder Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032
Figure 62: Asia Pacific Atrial Occluder Market Value (US$ Mn) by End User, 2022-2032
Figure 63: Asia Pacific Atrial Occluder Market Value (US$ Mn) by Country, 2022-2032
Figure 64: Asia Pacific Atrial Occluder Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: Asia Pacific Atrial Occluder Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: Asia Pacific Atrial Occluder Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: Asia Pacific Atrial Occluder Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032
Figure 68: Asia Pacific Atrial Occluder Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032
Figure 69: Asia Pacific Atrial Occluder Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032
Figure 70: Asia Pacific Atrial Occluder Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 71: Asia Pacific Atrial Occluder Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 72: Asia Pacific Atrial Occluder Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 73: Asia Pacific Atrial Occluder Market Attractiveness by Procedure Of Positioning, 2022-2032
Figure 74: Asia Pacific Atrial Occluder Market Attractiveness by End User, 2022-2032
Figure 75: Asia Pacific Atrial Occluder Market Attractiveness by Country, 2022-2032
Figure 76: MEA Atrial Occluder Market Value (US$ Mn) by Procedure Of Positioning, 2022-2032
Figure 77: MEA Atrial Occluder Market Value (US$ Mn) by End User, 2022-2032
Figure 78: MEA Atrial Occluder Market Value (US$ Mn) by Country, 2022-2032
Figure 79: MEA Atrial Occluder Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: MEA Atrial Occluder Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: MEA Atrial Occluder Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: MEA Atrial Occluder Market Value (US$ Mn) Analysis by Procedure Of Positioning, 2017-2032
Figure 83: MEA Atrial Occluder Market Value Share (%) and BPS Analysis by Procedure Of Positioning, 2022-2032
Figure 84: MEA Atrial Occluder Market Y-o-Y Growth (%) Projections by Procedure Of Positioning, 2022-2032
Figure 85: MEA Atrial Occluder Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 86: MEA Atrial Occluder Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 87: MEA Atrial Occluder Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 88: MEA Atrial Occluder Market Attractiveness by Procedure Of Positioning, 2022-2032
Figure 89: MEA Atrial Occluder Market Attractiveness by End User, 2022-2032
Figure 90: MEA Atrial Occluder Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
